Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer.
Kogawa T, Doi A, Shimokawa M, Fouad TM, Osuga T, Tamura F, Mizushima T, Kimura T, Abe S, Ihara H, Kukitsu T, Sumiyoshi T, Yoshizaki N, Hirayama M, Sasaki T, Kawarada Y, Kitashiro S, Okushiba S, Kondo H, Tsuji Y.
Kogawa T, et al. Among authors: kawarada y.
Target Oncol. 2015 Mar;10(1):125-33. doi: 10.1007/s11523-014-0322-0. Epub 2014 May 27.
Target Oncol. 2015.
PMID: 24859798